Back to Search Start Over

Defining a Central Monitoring Capability: Sharing the Experience of TransCelerate BioPharma's Approach, Part 1.

Authors :
Wilson B
Provencher T
Gough J
Clark S
Abdrachitov R
de Roeck K
Constantine SJ
Knepper D
Lawton A
Source :
Therapeutic innovation & regulatory science [Ther Innov Regul Sci] 2014 Sep; Vol. 48 (5), pp. 529-535.
Publication Year :
2014

Abstract

Central monitoring, on-site monitoring, and off-site monitoring provide an integrated approach to clinical trial quality management. TransCelerate distinguishes central monitoring from other types of central data review activities and puts it in the context of an overall monitoring strategy. Any organization seeking to implement central monitoring will need people with the right skills, technology options that support a holistic review of study-related information, and adaptable processes. There are different approaches actively being used to implement central monitoring. This article provides a description of how companies are deploying central monitoring, as well as samples of the workflows that illustrate how some have implemented it. The desired outcomes include earlier, more predictive detection of quality issues. This paper describes the initial implementation steps designed to learn what organizational capabilities are necessary.

Details

Language :
English
ISSN :
2168-4804
Volume :
48
Issue :
5
Database :
MEDLINE
Journal :
Therapeutic innovation & regulatory science
Publication Type :
Academic Journal
Accession number :
30231442
Full Text :
https://doi.org/10.1177/2168479014546335